These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 11250040)

  • 21. Evaluation of newly developed ELISA using "MESACUP-2 test mitochondrial M2" kit for the diagnosis of primary biliary cirrhosis.
    Kadokawa Y; Omagari K; Hazama H; Ohba K; Masuda J; Kinoshita H; Hayashida K; Isomoto H; Mizuta Y; Murase K; Murata I; Kohno S
    Clin Biochem; 2003 May; 36(3):203-10. PubMed ID: 12726929
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reactivity of twenty-two cytotoxic human monoclonal HLA antibodies towards soluble HLA class I in an enzyme-linked immunosorbent assay (PRA-STAT).
    Mulder A; Kardol M; Regan J; Buelow R; Claas F
    Hum Immunol; 1997; 56(1-2):106-13. PubMed ID: 9455499
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A novel enzyme-linked immunosorbent assay method for the detection of human neutrophil antigen-2a antibodies.
    Bayat B; Werth S; Sachs UJ; Santoso S
    Transfusion; 2009 Sep; 49(9):1819-24. PubMed ID: 19497055
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of ELISA-detected anti-HLA antibodies precedes the development of bronchiolitis obliterans syndrome and correlates with progressive decline in pulmonary function after lung transplantation.
    Jaramillo A; Smith MA; Phelan D; Sundaresan S; Trulock EP; Lynch JP; Cooper JD; Patterson GA; Mohanakumar T
    Transplantation; 1999 Apr; 67(8):1155-61. PubMed ID: 10232567
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antibodies to private and public HLA class I epitopes in platelet recipients.
    Zimmermann R; Wittmann G; Zingsem J; Blasczyk R; Weisbach V; Eckstein R
    Transfusion; 1999 Jul; 39(7):772-80. PubMed ID: 10413287
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antibody screening by enzyme-linked immunosorbent assay using pooled soluble HLA in renal transplant candidates.
    Zaer F; Metz S; Scornik JC
    Transplantation; 1997 Jan; 63(1):48-51. PubMed ID: 9000659
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Determination of acceptable HLA mismatches in highly sensitized patients by soluble HLA class I ELISA inhibition.
    Koelman CA; van Beelen E; Witvliet MD; Doxiadis II; Claas FH
    Transplantation; 2000 Feb; 69(4):656-60. PubMed ID: 10708125
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Detection of panel-reactive anti-HLA class I antibodies by enzyme-linked immunosorbent assay or lymphocytotoxicity. Results of a blinded, controlled multicenter study.
    Buelow R; Mercier I; Glanville L; Regan J; Ellingson L; Janda G; Claas F; Colombe B; Gelder F; Grosse-Wilde H
    Hum Immunol; 1995 Sep; 44(1):1-11. PubMed ID: 8522449
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pretransplant rejection risk assessment through enzyme-linked immunosorbent assay analysis of anti-HLA class I antibodies.
    Regan J; Monteiro F; Speiser D; Kalil J; Pouletty P; Buelow R
    Am J Kidney Dis; 1996 Jul; 28(1):92-8. PubMed ID: 8712228
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Assessment of assay sensitivity and precision in a malaria antibody ELISA.
    Rajasekariah GH; Kay GE; Russell NV; Smithyman AM
    J Immunoassay Immunochem; 2003; 24(1):89-112. PubMed ID: 12680609
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Detection of anti-HLA antibodies with flow cytometry in needle core biopsies of renal transplants recipients with chronic allograft nephropathy.
    Martin L; Guignier F; Bocrie O; D'Athis P; Rageot D; Rifle G; Justrabo E; Mousson C
    Transplantation; 2005 May; 79(10):1459-61. PubMed ID: 15912120
    [TBL] [Abstract][Full Text] [Related]  

  • 32. False-negative results in anti-HLA antibody detection by Sangstat ELISA: complement dependent cytotoxicity is not yet obsolete.
    Pierquin A; Masson D; Toupance O; Tabary T; Bougy F; Bensa JC; Chanard J; Cohen JH
    Transplantation; 1996 Nov; 62(10):1533-4. PubMed ID: 8958290
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anti-HLA antibodies interfere in the detection of soluble HLA class I molecules.
    Koelman CA; Ensink W; Mulder A; Tanke J; Doxiadis II; Claas FH
    Hum Immunol; 1999 May; 60(5):414-23. PubMed ID: 10447400
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Detection of HLA class I and II antibodies by ELISA and complement-dependent cytotoxicity before and after transplantation.
    Christiaans MH; Nieman F; van Hooff JP; van den Berg-Loonen EM
    Transplantation; 2000 Mar; 69(5):917-27. PubMed ID: 10755551
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of the established standard complement-dependent cytotoxicity and flow cytometric crossmatch assays with a novel ELISA-based HLA crossmatch procedure.
    Altermann WW; Seliger B; Sel S; Wendt D; Schlaf G
    Histol Histopathol; 2006 Oct; 21(10):1115-24. PubMed ID: 16835834
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Denatured class I human leukocyte antigen antibodies in sensitized kidney recipients: prevalence, relevance, and impact on organ allocation.
    Visentin J; Guidicelli G; Bachelet T; Jacquelinet C; Audry B; Nong T; Dubois V; Moreau JF; Lee JH; Couzi L; Merville P; Taupin JL
    Transplantation; 2014 Oct; 98(7):738-44. PubMed ID: 25289917
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sensitivity and specificity of commercial ELISA kits for screening anti-LAV/HTLV III.
    Gürtler LG; Eberle J; Lorbeer B; Deinhardt F
    J Virol Methods; 1987 Jan; 15(1):11-23. PubMed ID: 3468119
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HLA and MICA allosensitization patterns among patients supported by ventricular assist devices.
    Askar M; Hsich E; Reville P; Nowacki AS; Baldwin W; Bakdash S; Daghstani J; Zhang A; Klingman L; Smedira N; Moazami N; Taylor DO; Starling RC; Gonzalez-Stawinski G
    J Heart Lung Transplant; 2013 Dec; 32(12):1241-8. PubMed ID: 24075503
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aortic valve allograft structural deterioration is associated with a subset of antibodies to human leukocyte antigens.
    Dignan R; O'Brien M; Hogan P; Thornton A; Fowler K; Byrne D; Stephens F; Harrocks S
    J Heart Valve Dis; 2003 May; 12(3):382-90; discussion 390-1. PubMed ID: 12803340
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Platelet antibody screening by flow cytometry is more sensitive than solid phase red cell adherence assay and lymphocytotoxicity technique: a comparative study in Thai patients.
    Buakaew J; Promwong C
    Asian Pac J Allergy Immunol; 2010; 28(2-3):177-84. PubMed ID: 21038788
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.